CancerVAX, Inc.
CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment Platform that uses artificial intelligence to disguise cancer cells to look like measles, thereby tricking the body's immune system into killing them.
Funding history
About CancerVAX, Inc.
How much funding has CancerVAX, Inc. raised?
CancerVAX, Inc. has raised $1.5M in total funding. The most recent round was Seed.
Where is CancerVAX, Inc. headquartered?
CancerVAX, Inc. is headquartered in Santa Barbara, CA.
What does CancerVAX, Inc. do?
CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment Platform that uses artificial intelligence to disguise cancer cells to look like measles, thereby tricking the body's immune system into killing them.
What problem does CancerVAX, Inc. solve?
Millions die each year because the body does not easily recognize and kill cancer cells, and other immunotherapies have had very limited success teaching the immune system to recognize cancer.
What's CancerVAX, Inc.'s solution?
CancerVax is a pre-clinical biotech developing an AI-powered, injectable Universal Cancer Treatment Platform that detects, marks, and kills only cancer cells using the body's own immune system.
What makes CancerVAX, Inc. different?
Instead of teaching the immune system to recognize cancer directly, their approach disguises cancer cells to look like a disease the body already recognizes (such as measles), 'tricking' the immune system into attacking them.
What makes CancerVAX, Inc. notable?
Founded by Ryan Davies in 2021 and led by CEO Byron Elton, the company has raised funds through equity crowdfunding on StartEngine.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
